RAPP

Latest SEC Filings & News for RAPP

1 most recent filing and news item mentioning RAPP. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/RAPP/news?limit=20"

Pull RAPP filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 5, 2026Neutral

Rapport Reports Q2 2026 Financials and Initiates RAP-219 Phase 3 Trials

Rapport Therapeutics reported Q2 2026 financials and announced the initiation of FOCUS 1 and 2 Phase 3 trials for RAP-219. The company maintains strong liquidity expected to fund operations into 2029. Analysis: This clinical advancement represents a significant milestone for the

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.